2014
Use of Renin–Angiotensin System Blockers in Acute Coronary Syndromes
Bainey K, Armstrong P, Fonarow G, Cannon C, Hernandez A, Peterson E, Peacock W, Laskey W, Zhao X, Schwamm L, Bhatt D. Use of Renin–Angiotensin System Blockers in Acute Coronary Syndromes. Circulation Cardiovascular Quality And Outcomes 2014, 7: 227-235. PMID: 24569634, DOI: 10.1161/circoutcomes.113.000422.Peer-Reviewed Original ResearchConceptsAngiotensin receptor blockersAcute coronary syndromeACEI/angiotensin receptor blockerACEI/ARB therapyCoronary artery bypassCoronary syndromeAmerican CollegeARB therapyArtery bypassRenal insufficiencyMyocardial infarctionCardiology/American Heart Association class ICardiology/American Heart Association guidelinesGuidelines-Coronary Artery Disease programHospital coronary artery bypassRenin-angiotensin system blockersAmerican Heart Association guidelinesU.S. National RegistryHeart Association guidelinesRate of treatmentQuality improvement effortsEligible patientsSystem blockersReceptor blockersHospital discharge
2011
Use of Telemedicine and Other Strategies to Increase the Number of Patients That May Be Treated with Intravenous Thrombolysis
Silva G, Schwamm L. Use of Telemedicine and Other Strategies to Increase the Number of Patients That May Be Treated with Intravenous Thrombolysis. Current Neurology And Neuroscience Reports 2011, 12: 10-16. PMID: 21997715, DOI: 10.1007/s11910-011-0235-6.Peer-Reviewed Original ResearchConceptsAcute ischemic strokeUse of telemedicineIntravenous thrombolysisIschemic strokeIntravenous tissue plasminogen activator useAdult long-term disabilityTissue plasminogen activator useLong-term disabilityAmerican Heart AssociationNumber of patientsRecruitment of patientsRate of treatmentHelp of telemedicineThrombolysis trialsHeart AssociationStroke NetworkStroke systemsTelestroke networkTelestroke systemCurrent evidencePatientsThrombolysisStrokeCareTelemedicine